FMD reduced the number of glial cells and the release of TNF- and IL-1 in PD mice
Phase 2 trial establishing 24.2% mean weight loss at 12mg over 48 weeks, with dose-response data across the 1mg to 12mg range
Following the same reasoning, another group manipulated CaP cells to overexpress an miRNA of interest (miR-17-92a), and identified PAINT as a lncRNA that is upregulated in CaP where its expression correlates positively with clinical CaP stages and mediated epithelail-mesenchymal transition [130]
2024 | 10:50AM (IST) Manufacturer details F-115, Kanakia Zillion, LBS-CST Road Junction, Bandra Kurla Complex, Annexe, Mumbai, 400070 Country of origin: INDIA Expiry on or after: November 2026 In case of any issues, contact us: Was this product description useful
10.1038/nrgastro.2017.119 46 JrgensenJ.MortensenP